Jarno Robin, serves as Pharma Business Development Director at Sani Membranes where he is responsible for identifying new opportunities for Vibro® Membrane Filtration (VMF) Technology in pharmaceutical applications and setting up collaborations with industrial partners and universities to publish data. Vibro® Technology enables next level of process intensification with results not possible with any other filtration technology. He has a long career as principal scientist at NOVO NORDISK/Denmark, upstream process development director at SANOFI/France, Drug Substance MSAT director LEO Pharma/Denmark. He has >25 years working with continuous processes mainly upstream. Major achievement with implementation of ATF from lab-scale to production scale, SUB implementation and cultivation medium development.